GO:0038203 TORC2 signaling: Growth Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038203 (TORC2 signaling) describes the intracellular signal transduction cascade mediated by TORC2, a complex containing TOR (rapamycin-insensitive companion of TOR) and Rictor.
• TORC2 is a master regulator of cell growth, metabolism, and survival, and its dysfunction is linked to cancer, metabolic disorders, and neurodegeneration.
• The core TORC2 components include TOR, Rictor, LST8, and SIN1, which together phosphorylate AGC-family kinases such as AKT, SGK, and PKC.
• TORC2 signaling is conserved from yeast to humans, with model organisms like Saccharomyces cerevisiae and Schizosaccharomyces pombe providing key mechanistic insights.
• Research tools such as CRISPR knockout, point mutation, and knock-in models are essential to dissect TORC2 gene function and its role in disease.
• EDITGENE provides custom CRISPR cell models and screening services to accelerate TORC2 signaling research.
Description
TORC2 signaling (GO:0038203) is a fundamental intracellular pathway that orchestrates cell growth, proliferation, and survival in response to nutrients and growth factors. The target of rapamycin complex 2 (TORC2) is a multi-protein kinase complex that is conserved from yeast to humans and is defined by the presence of TOR (rapamycin-insensitive companion of TOR) in association with Rictor (regulatory-associated protein of TOR) and other signaling components. Unlike TORC1, TORC2 is not acutely inhibited by rapamycin and primarily phosphorylates AGC-family kinases, including AKT, SGK, and PKC, to regulate diverse cellular processes. Dysregulation of TORC2 signaling has been implicated in a wide range of human pathologies, including cancer, osteoarthritis, metabolic disorders, and neurodegenerative diseases. In yeast, TORC2 signaling is essential for cell proliferation under glucose-limited, nitrogen-replete conditions and for mitochondrial degradation induced by iron starvation. The pathway also cross-talks with other signaling networks such as MAPK and casein kinase 1, highlighting its integrative role in cellular decision-making. For researchers, understanding TORC2 signaling requires a combination of genetic, biochemical, and imaging approaches. CRISPR-based gene editing has emerged as a powerful tool to create knockout, point-mutation, and knock-in models to study TORC2 components and their downstream effectors. This article provides a comprehensive overview of GO:0038203, covering its definition, core mechanisms, key genes, disease relevance, and research methods, with a focus on how EDITGENE's services can support your studies.
TORC2 signaling At A Glance
| GO ID | GO:0038203 |
|---|---|
| GO term | TORC2 signaling |
| Ontology | biological_process |
| Synonym | TORC2 signal transduction |
| Major function | Mediates intracellular signals that regulate cell growth, proliferation, metabolism, and survival through phosphorylation of AGC-family kinases. |
| Key components | TOR, Rictor, LST8, SIN1, and downstream effectors such as AKT, SGK, and PKC. |
| Conservation | Conserved from yeast to humans; model organisms include Saccharomyces cerevisiae and Schizosaccharomyces pombe. |
| Disease relevance | Implicated in cancer, osteoarthritis, metabolic disorders, and neurodegeneration. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, proteomics, and imaging. |
What Is GO:0038203?
According to the Gene Ontology, TORC2 signaling (GO:0038203) is defined as a series of intracellular molecular signals mediated by TORC2; TOR (rapamycin-insensitive companion of TOR) in complex with at least Rictor (regulatory-associated protein of TOR), or orthologs of, and other signaling components. In simpler terms, it is the entire cascade of events that occurs when the TORC2 protein complex transmits signals inside a cell, ultimately affecting processes such as growth, metabolism, and survival.
Why Is TORC2 signaling Important in Cell Biology?
TORC2 signaling is critically important because it serves as a central hub that integrates nutrient and growth factor signals to control fundamental cellular processes such as proliferation, survival, and metabolism. Its dysregulation is associated with major human diseases, including cancer, where aberrant TORC2 activity promotes tumor growth and survival, and metabolic disorders such as osteoarthritis. Understanding TORC2 signaling at the molecular level is therefore essential for developing targeted therapies and for interpreting how cells respond to environmental cues.
• Regulates cell growth and proliferation in response to nutrients and growth factors.
• Phosphorylates and activates AGC kinases including AKT, SGK, and PKC, which control survival and metabolism.
• Plays a key role in glucose and lipid metabolism, and its dysfunction contributes to metabolic diseases.
• Implicated in cancer progression, making it a potential therapeutic target.
• Involved in osteoarthritis pathogenesis through PI3K/AKT/mTOR signaling.
• Essential for cell proliferation under glucose-limited conditions in fission yeast.
• Regulates mitochondrial degradation in response to iron starvation in Schizosaccharomyces pombe.
• Cross-talks with MAPK and casein kinase 1 signaling networks.
• Conserved across eukaryotes, enabling mechanistic studies in yeast models.
• Provides a paradigm for understanding rapamycin-insensitive mTOR functions.
What Happens During TORC2 signaling?
Activation of TORC2 by upstream signals
In simple terms: TORC2 is switched on by cues such as nutrients and growth factors.
TORC2 signaling is initiated when upstream signals, including growth factors and nutrients, lead to the activation of the TORC2 complex. This activation involves the assembly of TOR with Rictor, LST8, and SIN1, and is regulated by phosphorylation events and membrane recruitment. In budding yeast, casein kinase 1 controls components of the TORC2 signaling network, adding an additional layer of regulation. The activated TORC2 then phosphorylates downstream targets to propagate the signal.
Phosphorylation of AGC-family kinases
In simple terms: TORC2 adds phosphate groups to key kinases like AKT to turn them on.
A major function of TORC2 is to phosphorylate the hydrophobic motif of AGC-family kinases, including AKT (at Ser473), SGK, and PKC. This phosphorylation is required for full activation of these kinases, which then regulate diverse downstream effectors involved in cell survival, growth, and metabolism. For example, AKT phosphorylation by TORC2 promotes cell survival and proliferation, and its dysregulation is common in cancer.
Downstream signaling and cellular responses
In simple terms: Once activated, these kinases trigger changes in the cell, such as growth and survival.
Following phosphorylation by TORC2, AGC kinases propagate signals to downstream targets such as FOXO transcription factors, mTORC1, and metabolic enzymes. This leads to increased protein synthesis, cell cycle progression, and inhibition of apoptosis. In yeast, TORC2 signaling ensures cell proliferation under glucose-limited, nitrogen-replete conditions, and regulates mitochondrial degradation induced by iron starvation. These responses highlight the pathway's role in adapting cellular metabolism to environmental stress.
Cross-talk with other signaling pathways
In simple terms: TORC2 does not work alone; it communicates with other signaling systems.
TORC2 signaling intersects with multiple other pathways, including the MAPK cascade and casein kinase 1 signaling. In Schizosaccharomyces pombe, TORC2 and MAPK pathways coordinately regulate mitochondrial degradation during iron starvation. In budding yeast, casein kinase 1 controls TORC2 components, influencing the network's output. Such cross-talk enables the cell to integrate diverse inputs and fine-tune its response, and it also complicates the interpretation of genetic perturbations, necessitating careful experimental design.
Feedback regulation and termination
In simple terms: The signal is eventually turned off to prevent overactivity.
TORC2 signaling is subject to feedback regulation. For instance, mTORC1 downstream of AKT can negatively feedback on TORC2 activation, and phosphatases can dephosphorylate TORC2 substrates. In yeast, the TORC2-dependent signaling network is dynamically regulated in response to nutrient availability. Proper termination is crucial, as sustained TORC2 activity can lead to pathological conditions such as cancer.
Key Genes Involved in GO:0038203 TORC2 signaling
The following table lists key genes and proteins involved in TORC2 signaling, along with their major roles and relevance for research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TOR (mTOR) | Core kinase of TORC2; phosphorylates AGC kinases | Central to pathway; target for inhibitors; mutated in cancers |
| RICTOR | Essential scaffold protein of TORC2 | Required for complex assembly and substrate recruitment; knockout abolishes TORC2 signaling |
| LST8 (mLST8) | Stabilizes TORC2 complex | Essential for TORC2 integrity; knockout affects both TORC1 and TORC2 |
| SIN1 (MAPKAP1) | Subunit that mediates substrate binding | Knockout impairs AKT phosphorylation; links TORC2 to stress responses |
| AKT1 | Downstream effector kinase phosphorylated by TORC2 | Key survival kinase; mutations in cancer; target for therapy |
| SGK1 | AGC kinase phosphorylated by TORC2 | Regulates ion transport and cell survival; implicated in hypertension and cancer |
| PKCα | AGC kinase phosphorylated by TORC2 | Controls cell polarity and proliferation; involved in cancer |
| FOXO1 | Transcription factor inhibited by AKT | Regulates apoptosis and metabolism; downstream of TORC2 |
| MAPK1 (ERK2) | Cross-talk with TORC2 in yeast | Regulates mitochondrial degradation under iron starvation |
| CSNK1 (Casein kinase 1) | Regulates TORC2 components in budding yeast | Controls TORC2 network dynamics; potential target for modulation |
| RHO1 | Small GTPase in yeast TORC2 signaling | Regulates cell wall integrity; upstream of TORC2 |
| SLM1/2 | Pleckstrin homology domain proteins in yeast | Downstream effectors of TORC2; regulate actin polarization |
| Ypk1/2 | Yeast AGC kinases phosphorylated by TORC2 | Essential for sphingolipid synthesis and stress response |
| Gad8 | Fission yeast AGC kinase | Mediates TORC2-dependent growth and mitochondrial degradation |
| Ste20 | Fission yeast kinase | Cross-talks with TORC2 under iron starvation |
| Pkc1 | Yeast PKC homolog | Regulates cell wall integrity downstream of TORC2 |
| Tor2 | Yeast TOR kinase in TORC2 | Essential for growth; rapamycin-insensitive |
| Avo1/2/3 | Yeast SIN1/Rictor/LST8 orthologs | Components of yeast TORC2; required for complex function |
How Is TORC2 signaling Regulated?
TORC2 signaling is regulated at multiple levels. Upstream, growth factors and nutrients activate the pathway through mechanisms involving PI3K and small GTPases. In budding yeast, casein kinase 1 phosphorylates and controls components of the TORC2 network, thereby modulating its activity. Additionally, feedback loops from mTORC1 and other kinases fine-tune TORC2 output. The pathway also cross-talks with MAPK signaling, which can influence TORC2-dependent processes such as mitochondrial degradation under iron starvation. These regulatory mechanisms ensure that TORC2 signaling is appropriately tuned to cellular and environmental conditions.
TORC2 signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RICTOR | Cancer (various solid tumors) | Knockout in cancer cell lines to assess proliferation and AKT phosphorylation |
| AKT1 | Cancer, metabolic syndrome | Point mutation (e.g., E17K) knock-in to study constitutive activation |
| SGK1 | Hypertension, cancer | Overexpression in renal or cancer cells to study ion transport and survival |
| PKCα | Cancer, immune disorders | Knockout in T cells to study polarity and activation |
| mTOR | Cancer, neurodegeneration | Knock-in of rapamycin-resistant mutation to dissect TORC2-specific functions |
TORC2 signaling in cancer
Dysregulation of TORC2 signaling is frequently observed in human cancers. Aberrant activation of AKT, a key TORC2 substrate, promotes tumor cell survival, proliferation, and metastasis. Overexpression or mutation of TORC2 components, such as RICTOR, has been linked to various malignancies, making the pathway an attractive target for anticancer therapy. Inhibitors targeting mTOR, which is the core kinase of both TORC1 and TORC2, are in clinical use, but their efficacy is limited by feedback activation of TORC2.
TORC2 signaling in osteoarthritis
The PI3K/AKT/mTOR signaling pathway, which includes TORC2, plays a critical role in the pathogenesis of osteoarthritis. Activation of this pathway in chondrocytes contributes to cartilage degradation and inflammation. Targeting TORC2 signaling may therefore offer therapeutic benefits for osteoarthritis patients.
TORC2 signaling in metabolic and neurodegenerative disorders
TORC2 signaling is essential for metabolic homeostasis, and its dysfunction has been implicated in obesity, type 2 diabetes, and non-alcoholic fatty liver disease. In the nervous system, TORC2 regulates neuronal survival and synaptic plasticity, and its dysregulation is associated with neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. However, the precise mechanisms remain under investigation, and further studies using genetic models are needed.
From TORC2 signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of RICTOR in TORC2 assembly and AKT phosphorylation? | RICTOR knockout cell line (e.g., HEK293T) |
| How does a specific point mutation in AKT affect TORC2-mediated phosphorylation? | AKT point-mutation knock-in (e.g., S473A) |
| Can we visualize TORC2 localization in live cells? | Tagged knock-in of RICTOR with GFP or HaloTag |
| What are the downstream transcriptional changes upon TORC2 activation? | Overexpression of constitutively active AKT followed by RNA-seq |
| How does TORC2 cross-talk with MAPK signaling in yeast? | Double knockout of TORC2 and MAPK components in S. pombe |
| What is the effect of TORC2 inhibition on cell growth? | CRISPR knockout of TOR or RICTOR followed by growth assays |
How to Study the TORC2 signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Study essentiality of TORC2 components |
| Point mutation knock-in | Effect of specific amino acid changes | Dissect phosphorylation sites in AKT |
| Western blot | Protein expression and phosphorylation | Measure TORC2 activity via p-AKT S473 |
| Co-immunoprecipitation | Protein-protein interactions | Assess TORC2 complex assembly |
| RNA-seq | Transcriptome changes | Identify downstream transcriptional networks |
| Phosphoproteomics | Global phosphorylation events | Map TORC2 substrate specificity |
| Live-cell imaging | Subcellular localization and dynamics | Track TORC2 recruitment to membranes |
| Growth assays | Cell proliferation and viability | Evaluate TORC2 requirement under stress |
Genetic perturbation with CRISPR
CRISPR-Cas9 technology enables precise knockout, point mutation, and knock-in of TORC2 signaling genes. Knockout of RICTOR or SIN1 abolishes TORC2 function, while point mutations in AKT (e.g., S473A) prevent its phosphorylation by TORC2. These models are essential to establish causality between specific residues and downstream signaling.
Biochemical assays for TORC2 activity
Immunoblotting with phospho-specific antibodies against AKT Ser473, SGK, and PKC substrates is commonly used to measure TORC2 activity. Co-immunoprecipitation can assess complex integrity, and in vitro kinase assays with recombinant TORC2 can directly measure catalytic activity.
Transcriptomics and proteomics
RNA sequencing (RNA-seq) and quantitative proteomics can reveal global changes in gene expression and protein phosphorylation upon TORC2 perturbation. These approaches help identify downstream effectors and feedback mechanisms, and are particularly useful in yeast models where TORC2 regulates metabolic genes.
Imaging and live-cell analysis
Fluorescence microscopy of tagged TORC2 components (e.g., GFP-RICTOR) allows visualization of complex localization and dynamics. Live-cell imaging combined with FRET-based biosensors can monitor AKT activity in real time, providing spatiotemporal insights into TORC2 signaling.
How CRISPR Can Be Used to Study GO:0038203 TORC2 signaling
Knockout
CRISPR knockout of TORC2 core components such as RICTOR, SIN1, or LST8 completely abolishes TORC2 signaling, leading to loss of AKT Ser473 phosphorylation and impaired cell growth. These models are invaluable for studying the essential functions of TORC2 in various cell types and for validating drug targets.
Point Mutation
Point mutations can be introduced into TORC2 substrates to prevent or mimic phosphorylation. For example, knock-in of AKT1 S473A blocks TORC2-mediated phosphorylation, while S473D mimics constitutive phosphorylation. Such models allow precise dissection of phosphorylation-dependent functions in signaling and disease.
Knock-in
Knock-in of tagged versions of TORC2 components (e.g., GFP-RICTOR, HaloTag-SIN1) enables live-cell imaging and proteomic analysis of the complex. Additionally, knock-in of disease-associated mutations (e.g., in AKT1) can model human pathologies and test targeted therapies.
Overexpression
Overexpression of wild-type or constitutively active TORC2 components (e.g., RICTOR, AKT1) can amplify pathway output and reveal downstream effects on cell growth, survival, and metabolism. This approach is useful for identifying novel substrates and feedback mechanisms, and for screening inhibitors.
How EDITGENE Supports TORC2 signaling Research
Researchers studying TORC2 signaling-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0038203 and its components.
Contact EDITGENE today to design your custom CRISPR model for TORC2 signaling research.
Frequently Asked Questions About TORC2 signaling
What is TORC2 signaling?
TORC2 signaling (GO:0038203) is a series of intracellular molecular signals mediated by the TORC2 complex, which contains TOR and Rictor, and regulates cell growth, metabolism, and survival.
What genes are involved in TORC2 signaling?
Key genes include TOR (mTOR), RICTOR, LST8, SIN1, AKT1, SGK1, and PKC, among others.
What is the difference between TORC1 and TORC2?
TORC1 is rapamycin-sensitive and controls protein synthesis, while TORC2 is rapamycin-insensitive and primarily phosphorylates AGC kinases like AKT to regulate survival and metabolism.
How is TORC2 signaling regulated?
It is regulated by growth factors, nutrients, casein kinase 1, and feedback loops from mTORC1 and MAPK pathways.
What diseases are associated with TORC2 signaling?
Dysregulation is linked to cancer, osteoarthritis, metabolic disorders, and neurodegenerative diseases.
What are the downstream targets of TORC2?
Major targets include AKT, SGK, and PKC, which are phosphorylated at their hydrophobic motifs to become fully active.
How can I study TORC2 signaling in the lab?
Common methods include CRISPR knockout, point mutation knock-in, Western blotting for phospho-AKT, and RNA-seq.
What model organisms are used for TORC2 research?
Saccharomyces cerevisiae and Schizosaccharomyces pombe are widely used due to their conserved TORC2 pathway.
What is the role of RICTOR in TORC2 signaling?
RICTOR is an essential scaffold protein that is required for TORC2 complex assembly and substrate recruitment.
How does TORC2 signaling affect metabolism?
It promotes glucose uptake, lipid synthesis, and mitochondrial function, and its dysfunction contributes to metabolic diseases.
Conclusion
TORC2 signaling (GO:0038203) is a central pathway that controls cell growth, survival, and metabolism through phosphorylation of AGC-family kinases. Its dysregulation is implicated in cancer, osteoarthritis, and metabolic disorders, making it a key research focus. Understanding the molecular mechanisms and regulatory networks of TORC2 requires robust genetic models and advanced analytical techniques. EDITGENE's CRISPR services provide the tools needed to dissect this pathway and accelerate therapeutic discovery.
References
- 1. Wang Y et al.. 2025. Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis.. Cell 188(25):7155-7174.e25 PMID: 41317732
- 2. Toyoda Y et al.. 2021. Fission Yeast TORC2 Signaling Pathway Ensures Cell Proliferation under Glucose-Limited, Nitrogen-Replete Conditions.. Biomolecules 11(10) PMID: 34680098
- 3. Sun K et al.. 2020. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review.. Osteoarthritis Cartilage 28(4):400-409 PMID: 32081707
- 4. Ragupathi A et al.. 2024. The mTORC2 signaling network: targets and cross-talks.. Biochem J 481(2):45-91 PMID: 38270460
- 5. Szwed A et al.. 2021. Regulation and metabolic functions of mTORC1 and mTORC2.. Physiol Rev 101(3):1371-1426 PMID: 33599151
- 6. Li R et al.. 2025. TORC2 and MAPK signaling pathways regulate mitochondrial degradation induced by iron starvation in Schizosaccharomyces pombe.. J Biol Chem 301(9):110524 PMID: 40716740
- 7. Roelants FM et al.. 2017. The TORC2-Dependent Signaling Network in the Yeast Saccharomyces cerevisiae.. Biomolecules 7(3) PMID: 28872598
- 8. Lucena R et al.. 2024. Casein kinase 1 controls components of a TORC2 signaling network in budding yeast.. J Cell Sci 137(24) PMID: 39704566
